Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Schiffman

Lion Biotechnologies has appointed Gregory Schiffman as CFO. Schiffman brings fifteen years of experience holding leadership roles in financial operations and strategy in publicly-traded healthcare companies, such as Dendreon, Affymetrix, and Applied Biosystems. Most recently, he served as executive vice president and CFO of StemCells. Prior to StemCells, Schiffman served as executive vice president and CFO of Dendron. Before his work in the healthcare industry, he held roles of increasing responsibility at Hewlett Packard, including serving as controller of its European personal computer manufacturing and distribution operations in Grenoble, France, and as manufacturing and controller of its Netmetrix division.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.